Articles

BRCC3 mutations in myeloid neoplasms

Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China;Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Department of Pathology and Tumor Biology, Kyoto University, Japan
Munich Leukemia Laboratory (MLL), Germany
Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, OH, USA
Department of Pathology and Tumor Biology, Kyoto University, Japan
Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Japan
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Munich Leukemia Laboratory (MLL), Germany
Department of Pathology and Tumor Biology, Kyoto University, Japan
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Department of Pathology and Tumor Biology, Kyoto University, Japan
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Munich Leukemia Laboratory (MLL), Germany
Department of Pathology and Tumor Biology, Kyoto University, Japan
Munich Leukemia Laboratory (MLL), Germany
Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, OH, USA
Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Japan
Department of Pathology and Tumor Biology, Kyoto University, Japan
Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Japan
Laboratory of Sequence Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Japan
Department of Hematology/Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA;Cancer Science Institute of Singapore, National University of Singapore
Institute of Medical Informatics, University of Münster, Germany
Institute of Medical Informatics, University of Münster, Germany
Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Japan
Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Japan;Laboratory of Sequence Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Japan
Munich Leukemia Laboratory (MLL), Germany
Munich Leukemia Laboratory (MLL), Germany
Munich Leukemia Laboratory (MLL), Germany
Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
Department of Pathology and Tumor Biology, Kyoto University, Japan
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA;Department of Pathology and Tumor Biology, Kyoto University, Japan
Vol. 100 No. 8 (2015): August, 2015 https://doi.org/10.3324/haematol.2014.111989